跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,927 条关于
“HPV+OPSCC”
全部
14,927
临床试验
13,531
药物
778
机构
10
资讯
608
去年
Naveris Showcases NavDx Test Advances for HPV-Associated Oropharyngeal Cancer Surveillance at ASTRO 2024
去年
De-escalated Radiation Therapy Reduces Toxicity While Maintaining Cure Rates in HPV-Positive Oropharyngeal Cancer
8个月前
BioAtla Secures $40 Million Funding to Advance Ozuriftamab Vedotin into Phase 3 Trial for Oropharyngeal Cancer
6个月前
BioAtla Initiates Strategic Review Process Amid Major Restructuring and 70% Workforce Reduction
5个月前
Ultrasensitive Blood Test HPV-DeepSeek Predicts Recurrence and Survival in HPV-Associated Head and Neck Cancer
3个月前
HPV cfDNA Demonstrates 95% Sensitivity for Detecting HPV-Driven Oropharyngeal Cancer and Predicts Recurrence Months Before Imaging
去年
China Approves First Domestically Developed 9-Valent HPV Vaccine, Becomes Second Country with Independent High-Valency HPV Production
去年
INOVIO Advances DNA Medicine Pipeline with Focus on INO-3107 BLA Submission for RRP
6个月前
Daré Bioscience Receives FDA Clearance for Phase 2 Trial of DARE-HPV, First Potential Treatment for Persistent High-Risk HPV Infection
去年
Novel uPAR-Targeting Imaging Agent FG001 Shows Promise in Oral and Oropharyngeal Cancer Surgery
第 1 页,共 61 页
上一页
下一页